Neuland Laboratories has informed that the United States Food and Drug Administration (US FDA) inspected one of the Manufacturing facilities of the Company (Unit 2), located at Pashmylaram, Patancheru Mandal, Sangareddy District, from 26th to 29th of November, 2018. The inspection at Unit 2 by the US FDA has been successfully completed, with no observations under Form 483.
The above information is a part of company’s filings submitted to BSE.